Eli Lilly to Build $5 Billion Drug Manufacturing Plant in Virginia

Published: Tuesday, September 16, 2025 at 9:00 pm

Eli Lilly to Invest $5 Billion in New Virginia Drug Manufacturing Plant

Pharmaceutical giant Eli Lilly announced plans this week to construct a $5 billion drug manufacturing facility in Virginia. The project, expected to be completed within five years, is projected to create over 650 high-paying jobs, encompassing roles for engineers, scientists, and technicians. The company also anticipates the creation of 1,800 construction jobs.

The announcement comes amidst a backdrop of political pressure to bolster domestic drug manufacturing. President Donald Trump has previously voiced intentions to impose tariffs on pharmaceuticals imported from overseas. The disruptions to the supply chain during the COVID-19 pandemic further highlighted the need for increased domestic production.

The new facility will be located west of Richmond, Virginia, in Goochland County. This investment is part of a larger commitment by Eli Lilly, which previously announced plans to invest over $27 billion in new manufacturing facilities. The company has invested a total of $50 billion since 2020. Eli Lilly stated that three additional U.S. manufacturing sites will be announced soon.

According to Eli Lilly, the new facility will be its first bioconjugate facility, representing a significant milestone for the company. The company emphasized its commitment to transformative technologies, sustainability efforts, and community partnerships.

BNN's Perspective:

This investment by Eli Lilly is a welcome development, promising economic benefits and strengthening the domestic pharmaceutical supply chain. While the political motivations behind the push for domestic manufacturing are clear, the potential for job creation and increased self-reliance in the healthcare sector is a positive step. The long-term impact of these investments will depend on various factors, including the stability of the regulatory environment and the ability of the U.S. to attract and retain skilled workers in the pharmaceutical industry.

Keywords: Eli Lilly, drug manufacturing, Virginia, investment, jobs, pharmaceuticals, supply chain, manufacturing facility, Goochland County, bioconjugate, tariffs, Donald Trump, Glenn Youngkin, economy, innovation

Full Story